Latest News

All News Media Interview
Galux and ISU Abxis Sign MOU to Collaborate on AI-Driven Drug Discovery
NEWS
November 14, 2025

Galux and ISU Abxis Sign MOU to Collaborate on AI-Driven Drug Discovery

Read More
Galux and Woojung Bio Forge Strategic Partnership to Accelerate AI-Driven Therapeutics Development
NEWS
September 30, 2025

Galux and Woojung Bio Forge Strategic Partnership to Accelerate AI-Driven Therapeutics Development

Read More
Galux Demonstrates De Novo Antibody Design With Structural and Functional Validation Across Eight Targets
NEWS
September 23, 2025

Galux Demonstrates De Novo Antibody Design With Structural and Functional Validation Across Eight Targets

Read More
Galux and HanAll Biopharma Initiate Strategic Collaboration to Develop AI-Designed Antibody Therapeutics for Cancer
NEWS
June 11, 2025

Galux and HanAll Biopharma Initiate Strategic Collaboration to Develop AI-Designed Antibody Therapeutics for Cancer

Read More
Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets
NEWS
March 17, 2025

Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets

Read More
Galux Unveils Breakthrough AI Technology for Therapeutic Antibody Loop Design
NEWS
September 19, 2024

Galux Unveils Breakthrough AI Technology for Therapeutic Antibody Loop Design

Read More
Galux and LG Chem Initiate Joint Research on AI-Powered Cancer Drug Development
NEWS
August 26, 2024

Galux and LG Chem Initiate Joint Research on AI-Powered Cancer Drug Development

Read More